2025-01-09 IDOPRESS
WUHU,China,Jan. 8,2025 -- On January 8th,2025,JETOUR announced a groundbreaking partnership with global EDM icon Alan Walker. As part of this collaboration,Walker will create a brand theme song for JETOUR,blending the brand's "Travel+" philosophy with his unique musical style. Scheduled for worldwide release in January 2025,the song aims to transcend cultural and geographical boundaries,inspiring audiences globally to embrace travel and pursue a better life.

Since his 2014 breakthrough with "Fade," Alan Walker has captivated millions with his signature electronic sound and ethereal vocals. His global hit "Faded" amassed over 1.2 billion views on YouTube and topped charts worldwide. With a strong presence on social media and platforms like Spotify,Walker has become a leading figure in electronic music.
This collaboration reflects JETOUR and Walker's shared passion for travel,freedom,and dreams. Walker's music,known for evoking a sense of exploration and aspiration,aligns seamlessly with JETOUR's strategic "Travel+" positioning. The partnership will infuse "Travel+ Music" with youthful,fashionable,and vibrant energy,enhancing JETOUR's global influence.
Music,a universal language,serves as a bridge connecting humanity. Through this collaboration,JETOUR and Alan Walker embody the vision of "One World,One JETOUR,One Travel+," combining music and travel to create a richer,more memorable experience. The tailor-made theme song promises to awaken an inner yearning for freedom and adventure,bringing art and travel together in a new way.
Looking ahead,JETOUR will continue its commitment to the "Travel+" strategy,offering diverse experiences and encouraging global consumers to explore the infinite charm of travel. This collaboration marks another step in ensuring every journey becomes a beautiful and unforgettable adventure.
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map